Skip to content

Clinical trials

Phase 1/2 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 1/2 Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20053
20061
20072
20091
20101
20112
20123
20142
20153
20161
20172
20186
20192
20202
20218
20224
20231
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting6
Not yet recruiting4
Unknown status4
Terminated3
Withdrawn3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sadat City University4
Laureate Institute for Brain Research, Inc.2
Mclean Hospital2
Medical Research Council Cognition and Brain Sciences Unit2
New York State Psychiatric Institute2
University of Cincinnati2
University of Texas Southwestern Medical Center2
Alkermes, Inc.1
BioLite, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder56
Mood Disorders4
Alcoholism3
Bipolar Disorder3
Dysthymic Disorder3
Stress Disorders, Post-Traumatic3
Anxiety Disorders2
Depressive Disorder, Treatment-Resistant2
Generalized Anxiety Disorder2
Panic Disorder2

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.